FHTX
|
Foghorn Therapeutics Inc.
|
US
|
NASDAQ
|
GSK
|
GlaxoSmithKline PLC
|
US
|
NYSE
|
IMAB
|
I-Mab
|
US
|
NASDAQ
|
KNSA
|
Kiniksa Pharmaceuticals, Ltd.
|
US
|
NASDAQ
|
LIAN
|
LianBio
|
US
|
NASDAQ
|
LQDA
|
Liquidia Technologies, Inc.
|
US
|
NASDAQ
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
MNOV
|
MediciNova, Inc.
|
US
|
NASDAQ
|
MRK
|
Merck & Company, Inc.
|
US
|
NYSE
|
MYMD
|
MyMD Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
NHWK
|
NightHawk Biosciences, Inc.
|
US
|
AMEX
|
NVS
|
Novartis AG
|
US
|
NYSE
|
ORMP
|
Oramed Pharmaceuticals Inc.
|
US
|
NASDAQ
|
PFE
|
Pfizer, Inc.
|
US
|
NYSE
|
PHAT
|
Phathom Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
PROC
|
Procaps Group, S.A.
|
US
|
NASDAQ
|
PRTC
|
PureTech Health plc
|
US
|
NASDAQ
|
QLI
|
Qilian International Holding Group Ltd.
|
US
|
NASDAQ
|
SCPH
|
scPharmaceuticals Inc.
|
US
|
NASDAQ
|
SCYX
|
SCYNEXIS, Inc.
|
US
|
NASDAQ
|